Literature DB >> 12848809

Increased p-wave duration and p-wave dispersion in patients with aortic stenosis.

Hasan Turhan1, Ertan Yetkin, Ramazan Atak, Tayfun Altinok, Kubilay Senen, Mehmet Ileri, Hatice Sasmaz, Sengul Cehreli, Emine Kutuk.   

Abstract

BACKGROUND: P-wave dispersion (PWD), defined as the difference between the maximum and minimum P-wave duration, has been proposed as being useful for the prediction of paroxysmal atrial fibrillation (AF). AF is the most common arrhythmia and an important prognostic indicator for clinical deterioration in patients with aortic stenosis (AS). The aim of the present study was to evaluate PWD in patients with AS.
METHODS: The study population consisted of two groups: Group I consisted of 98 patients with AS (76 men, 22 women; aged 63 +/- 8 years) and group II consisted of 98 healthy subjects (same age and sex) without any cardiovascular disease. A 12-lead electrocardiogram was recorded for each subject. The P-wave duration was calculated in all leads of the surface electrocardiogram. The difference between the maximum and minimum P-wave duration was calculated and was defined as the PWD. All patients and control subjects were also evaluated by echocardiography to measure the left atrial diameter, left ventricular ejection fraction, left ventricular wall thicknesses, and the maximum and mean aortic gradients. Patients were also evaluated for the presence of paroxysmal AF.
RESULTS: Maximum P-wave duration and PWD of group I were found to be significantly higher than those of group II. In addition, patients with paroxysmal AF had significantly higher PWD than those without paroxysmal AF. There was no significant difference between the two groups regarding minimum P-wave duration. In addition, there was no significant correlation between echocardiographic variables and PWD.
CONCLUSION: PWD, indicating increased risk for paroxysmal AF, was found to be significantly higher in patients with AS than in those without it. Further assessment of the clinical utility of PWD for the prediction of paroxysmal AF in patients with severe AS will require longer prospective studies.

Entities:  

Mesh:

Year:  2003        PMID: 12848809      PMCID: PMC6932054          DOI: 10.1046/j.1542-474x.2003.08104.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  19 in total

1.  Effects of percutaneous mitral balloon valvuloplasty on P-wave dispersion in patients with mitral stenosis.

Authors:  Hasan Turhan; Ertan Yetkin; Kubilay Senen; M Birhan Yilmaz; Mehmet Ileri; Ramazan Atak; Sengul Cehreli; Emine Kutuk
Journal:  Am J Cardiol       Date:  2002-03-01       Impact factor: 2.778

2.  Electrocardiographic left atrial enlargement. Electrophysiologic, echocardiographic and hemodynamic correlates.

Authors:  M E Josephson; J A Kastor; J Morganroth
Journal:  Am J Cardiol       Date:  1977-06       Impact factor: 2.778

3.  Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation.

Authors:  P E Dilaveris; E J Gialafos; S K Sideris; A M Theopistou; G K Andrikopoulos; M Kyriakidis; J E Gialafos; P K Toutouzas
Journal:  Am Heart J       Date:  1998-05       Impact factor: 4.749

4.  Coronary heart disease and atrial fibrillation: the Framingham Study.

Authors:  W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal:  Am Heart J       Date:  1983-08       Impact factor: 4.749

5.  Atrial conduction: effects of extrastimuli with and without atrial dysrhythmias.

Authors:  A E Buxton; H L Waxman; F E Marchlinski; M E Josephson
Journal:  Am J Cardiol       Date:  1984-10-01       Impact factor: 2.778

6.  P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation.

Authors:  K Aytemir; N Ozer; E Atalar; E Sade; S Aksöyek; K Ovünç; A Oto; F Ozmen; S Kes
Journal:  Pacing Clin Electrophysiol       Date:  2000-07       Impact factor: 1.976

7.  [Neurohormonal profile in aortic valve stenosis].

Authors:  J F Ramirez-Gil; G Drobinski; A Carayon; R Isnard; O Hoffman; I Sotirov; E Chanton; G Montalescot; D Thomas
Journal:  Arch Mal Coeur Vaiss       Date:  1993-07

8.  The Canadian Registry of Atrial Fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation.

Authors:  C R Kerr; J Boone; S J Connolly; P Dorian; M Green; G Klein; D Newman; R Sheldon; M Talajic
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

9.  Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function.

Authors:  M J Suttorp; J H Kingma; E M Koomen; A van 't Hof; J G Tijssen; K I Lie
Journal:  Am J Cardiol       Date:  1993-03-15       Impact factor: 2.778

10.  Prolonged atrial conduction. A major predisposing factor for the development of atrial flutter.

Authors:  C V Leier; J A Meacham; S F Schaal
Journal:  Circulation       Date:  1978-02       Impact factor: 29.690

View more
  13 in total

1.  Meta-analysis of p-wave dispersion values in healthy individuals: the influence of clinical characteristics.

Authors:  Udi Nussinovitch
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

2.  Increases in P-wave duration and dispersion after hemodialysis are totally (or partially) due to the procedure-induced alleviation of the body fluid overload: a hypothesis with strong experimental support.

Authors:  John E Madias
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-04       Impact factor: 1.468

Review 3.  Clinical manifestations of Wilson disease in organs other than the liver and brain.

Authors:  Karolina Dzieżyc-Jaworska; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

4.  The relationship between R wave peak time and left ventricular mass index in patients with end-stage renal disease on hemodialysis.

Authors:  Macit Kalçık; Mucahit Yetim; Tolga Doğan; Barış Eser; İbrahim Doğan; Lütfü Bekar; Oğuzhan Çelik; Yusuf Karavelioğlu
Journal:  Int Urol Nephrol       Date:  2019-09-30       Impact factor: 2.370

5.  P-wave indices, distribution and quality control assessment (from the Framingham Heart Study).

Authors:  Jared W Magnani; Michael J Mazzini; Lisa M Sullivan; MaryAnn Williamson; Patrick T Ellinor; Emelia J Benjamin
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-01       Impact factor: 1.468

6.  P-wave dispersion in children with acute rheumatic fever.

Authors:  Celebi Kocaoglu; Ahmet Sert; Ebru Aypar; Bulent Oran; Dursun Odabas; Derya Arslan; Fatih Akin
Journal:  Pediatr Cardiol       Date:  2011-09-06       Impact factor: 1.655

Review 7.  P wave indices: current status and future directions in epidemiology, clinical, and research applications.

Authors:  Jared W Magnani; Mary Ann Williamson; Patrick T Ellinor; Kevin M Monahan; Emelia J Benjamin
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02

8.  P-wave duration and dispersion in patients with peripheral edema and its amelioration.

Authors:  John E Madias
Journal:  Indian Pacing Electrophysiol J       Date:  2007-01-01

9.  P wave dispersion is increased in pulmonary stenosis.

Authors:  Namik Ozmen; Bekir Sitki Cebeci; Ejder Kardesoglu; Turgay Celik; Mehmet Dincturk; Ergun Demiralp
Journal:  Indian Pacing Electrophysiol J       Date:  2006-01-01

10.  Prolonged PR interval predicts clinical recurrence of atrial fibrillation after catheter ablation.

Authors:  Junbeom Park; Tae-Hoon Kim; Jihei Sara Lee; Jin Kyu Park; Jae Sun Uhm; Boyoung Joung; Moon Hyoung Lee; Hui-Nam Pak
Journal:  J Am Heart Assoc       Date:  2014-10-07       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.